Showing results (801-810 of 1,171) with videos related to

Sort By:
Pageof 118
Nanoscale Horizons|February 15, 2021
Tumor-targeted gene therapy with lipid nanoparticles inhibits tumor-associated adipocytes and remodels the immunosuppressive tumor microenvironment in triple-negative breast cancerYun Liu, Karthik Tiruthani, Menglin Wang, et al.
Carcinogenesis|May 1, 1997
Urinary excretion of 3-methyladenine after consumption of fish containing high levels of dimethylamineL B Fay, C D Leaf, E Gremaud, et al.
Investigational New Drugs|January 1, 1997
An ECOG phase II study of amonafide in unresectable or recurrent carcinoma of the head and neck (PB390). Eastern Cooperative Oncology GroupA N Leaf, D Neuberg, E L Schwartz, et al.
Journal of Child and Family Studies|December 16, 2014
Maternal Relationship Insecurity and Depressive Symptoms as Moderators of Home Visiting Impacts on Child OutcomesFallon Cluxton-Keller, Lori Burrell, Sarah S Crowne, et al.
BMJ Open|December 9, 2017
Successfully implementing and embedding guidelines to improve the nutrition and growth of preterm infants in neonatal intensive care: a prospective interventional studyMark J Johnson, Alison A Leaf, Freya Pearson, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|October 21, 2024
Documented penicillin allergy and beta-lactam antibiotic use in Massachusetts long-term care facilities: opportunities for penicillin allergy delabelingKap Sum Foong, Shira Doron, Leslie Fowle, et al.
Behavior Analysis in Practice|December 11, 2023
Behavior Analysts' Use of Treatments for Individuals with Autism: Trends within the FieldKimberly B Marshall, Kristin S Bowman, Lisa Tereshko, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2010
Cutting edge: Cytosolic bacterial DNA activates the inflammasome via Aim2Sarah E Warren, Abraham Armstrong, M Kristina Hamilton, et al.
The American Journal of Physiology|October 1, 1989
n-3 fatty acids increase postischemic blood flow but do not reduce myocardial necrosisT Force, C D Malis, J L Guerrero, et al.
Medical Oncology (Northwood, London, England)|July 2, 2003
Phase III study of combined chemohormonal therapy in metastatic prostate cancer (ECOG 3882): an Eastern Cooperative Oncology Group studyAndrea N Leaf, Kathleen Propert, Chris Corcoran, et al.
Pageof 118